Related Experiment Video

Updated: Jun 4, 2026

Simple Continuous Glucose Monitoring in Freely Moving Mice
03:25

Simple Continuous Glucose Monitoring in Freely Moving Mice

Published on: February 24, 2023

Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes

Tadej Battelino1, Moshe Phillip, Natasa Bratina

  • 1Department of Pediatric Endocrinology, Diabetes and Metabolism, Faculty of Medicine, University Medical Centre-University Children’s Hospital, University of Ljubljana, Ljubljana, Slovenia. tadej.battelino@mf.uni-lj.si

Diabetes Care
|February 22, 2011
PubMed

Insights

Continuous glucose monitoring significantly reduced hypoglycemia time in type 1 diabetes patients. This technology also lowered glycated hemoglobin A1c levels, improving overall glycemic control.

Area of Science:

  • Endocrinology
  • Metabolic Diseases
  • Diabetes Management

Background:

  • Type 1 diabetes (T1D) management requires careful glucose level monitoring.
  • Hypoglycemia is a significant risk associated with intensive T1D therapy.
  • Continuous glucose monitoring (CGM) offers a potential tool for improved T1D management.

Purpose of the Study:

  • To evaluate the effectiveness of real-time continuous glucose monitoring (CGM) versus conventional blood glucose monitoring.
  • To assess the impact of CGM on the duration of hypoglycemia in individuals with T1D.
  • To determine changes in glycated hemoglobin A1c (HbA1c) levels with CGM use.

Main Methods:

  • A randomized, controlled, multicenter trial involving 120 children and adults with T1D.
  • Participants were assigned to either real-time CGM or conventional home monitoring with a blood glucose meter.
  • The primary outcome measured was time spent in hypoglycemia (<63 mg/dL) over 26 weeks.

Main Results:

  • The CGM group experienced significantly less time in hypoglycemia daily compared to the control group (0.48 vs. 0.97 h/day, P=0.03).
  • HbA1c levels were significantly lower in the CGM group at 26 weeks (difference -0.27%, P=0.008).
  • Individuals using CGM spent more time in the normoglycemic range (70-180 mg/dL) daily.

Conclusions:

  • Real-time continuous glucose monitoring is effective in reducing hypoglycemia in type 1 diabetes.
  • CGM use is associated with improved glycemic control, indicated by lower HbA1c levels.
  • Continuous glucose monitoring enhances time spent within the target blood glucose range for T1D patients.
Abstract

More Related Videos

Improving IV Insulin Administration in a Community Hospital12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain08:32

Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain

Published on: January 4, 2018

Related Concept Videos

Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...